An Australian stem cell and regenerative medicine company

ASX Announcements

25 Sep 2018 Appendix 3Y-Dr Paul Wotton
25 Sep 2018 Cleansing Notice
25 Sep 2018 Appendix 3B-Exercise of Options
18 Sep 2018 Cynata MSCs Ameliorate CRS in Preclinical Study
12 Sep 2018 Results of Meeting
05 Sep 2018 Director Loan Funded Shares-Voluntary Escrow Arrangement
03 Sep 2018 Cynata Advances to Official Meeting with Japanese PDMA
31 Aug 2018 Cynata to Present at Rodman & Renshaw Investor Conference
29 Aug 2018 Cynata GvHD Trial Meets all Safety & Efficacy Endpoints
24 Aug 2018 Updated Appendix 4G
22 Aug 2018 Appendix 4G
22 Aug 2018 Appendix 4E & Financial Statements
10 Aug 2018 Notice of General Meeting/Proxy Form
30 Jul 2018 Cymerus MSCs improve cardiac recovery in preclinical study
16 Jul 2018 Cleansing Notice
16 Jul 2018 Appendix 3B-Exercise of Options
11 Jul 2018 Cleansing Notice
11 Jul 2018 Appendix 3B-Exercise of Options
11 Jul 2018 June 2018 Quarterly Report
06 Jul 2018 Cleansing Notice
06 Jul 2018 Appendix 3B-Exercise of Options
01 Jul 2018 Cynata Enters Development Partnership with RCSI
25 Jun 2018 Product Development Program Update & Investor Presentation
20 Jun 2018 Positive 28-day Clinical Trial Data in Cohort B
17 Jun 2018 Research Collaboration with UNSW for Coronary Artery Disease
11 Jun 2018 Positive 6-Month Data from Cohort A in Phase 1 Trial in GvHD
04 Jun 2018 Cleansing Notice
04 Jun 2018 Appendix 3B
30 May 2018 Cynata's MSCs Effective in Model of Diabetic Wounds
29 May 2018 $5.2m placement of shares to Fidelity International
23 May 2018 Enrolment Completed in Cynata's Phase 1 Clinical Trial
22 May 2018 Cleansing Notice
22 May 2018 Appendix 3B-Exercise of Options
15 May 2018 Cleansing Notice
15 May 2018 Appendix 3B-Exercise of Options
07 May 2018 Becoming a substantial holder
07 May 2018 Notice of Allowance from EPO for Patent Application
27 Apr 2018 March 2018 Quarterly Report
24 Apr 2018 Cleansing Notice
24 Apr 2018 Appendix 3B-Exercise of Options
19 Apr 2018 CYP Completes Patent Application related to CAR-T Therapy
12 Apr 2018 Cynata to Present at ARM Investor Day
11 Apr 2018 Further US Patent Granted for Cynata Cymerus Technology
04 Apr 2018 Cleansing Notice
04 Apr 2018 Appendix 3B-Exercise of Options
28 Mar 2018 Cleansing Notice
28 Mar 2018 Appendix 3B-Exercise of Options
27 Mar 2018 FDA Grants Orphan Drug Designation to Cynata for CYP-001
13 Mar 2018 Cleansing Notice
13 Mar 2018 Appendix 3B-Exercise of Options